Frontiers in Clinical Diabetes and Healthcare

Aims & Scope

Frontiers in Clinical Diabetes and Healthcare is a multidisciplinary journal that contributes to the understanding of diabetes and its treatment in clinical settings.

Led by Field Chief Editor Dr.

Manfredi Rizzo (University of Palermo, Italy), Frontiers in Clinical Diabetes and Healthcare welcomes submissions in all areas of clinical diabetes research which improve treatment experiences and quality of practices for patients.

Manfredi Rizzo has been elected as a member of the Board of Directors of the International Atherosclerosis Society (IAS) for the years 2025-2027.

The IAS is a global network of the world's leading atherosclerotic cardiovascular disease experts who collaborate on the prevention and treatment of cardiometabolic diseases.

The society represents more than 40,000 clinicians across 70 countries.

Frontiers in Clinical Diabetes is currently indexed in PubMed Central (PMC), the DOAJ, Scopus, and Web of Science Emerging Sources Citation Index (ESCI).

Focusing on the clinical aspects of diabetes, the journal covers the following subject areas: • diabetes cardiovascular complications • diabetes clinical epidemiology • diabetes health services and health economics • diabetes inequalities • diabetes innovative devices • diabetes, lifestyle, and metabolic syndrome • diabetes multiorgan complications • diabetes nephropathy • diabetes nutrition and dietetics • diabetes and pregnancy • diabetes self-management • diabetes therapies.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,950.00 CHF. Learn more.

Explore journals without APCs for alternative publishing options.